The AI-based coronary artery disease (CAD) platform developer's upsized IPO indicates robust investor appetite for listings by medical technology companies

Section Partners Management LLC published this content on August 06, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 08, 2026 at 11:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]